Citius pharmaceuticals issues shareholder letter with corporate update on recent achievements and anticipated milestones for 2021

Cranford, n.j., feb. 16, 2021 /prnewswire/ -- citius pharmaceuticals, inc. ("citius" or the "company") (nasdaq: ctxr), a specialty pharmaceutical company developing and commercializing critical care drug products, today issued a shareholder letter providing a corporate update on the...
CTXR Ratings Summary
CTXR Quant Ranking